COc1ccc(CCNC(=O)CCCCCn2c(=O)[nH]c3cc(OC)c(OC)cc3c2=O)cc1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?